The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Kazia Therapeutics Limited(NASDAQ:KZIA) 
Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is GDC-0084, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. The company is also dev...
Kazia Therapeutics Days Receivable Outstanding ttm (DSO)
Kazia Therapeutics Op Cashflow Per Share ttm
Kazia Therapeutics Free Cashflow Per Share ttm
Kazia Therapeutics Cash Per Share ttm
Kazia Therapeutics P/S ratio ttm
Kazia Therapeutics (GAAP) P/E ratio ttm
Kazia Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.